Beat the Dow Jones With This Unstoppable Dividend Stock
The iconic Dow Jones needs no introduction to those fully immersed in the investing world. It is composed of 30 leading companies in the U.S. and stands as one of the country's oldest and most popular stock market indexes. Like other major U.S. indexes, it has delivered solid returns over the long run, so perhaps investing in an exchange-traded fund that tracks the Dow Jones isn't a bad idea.
However, some companies are more than capable of providing even better returns. Pharma giant AbbVie (NYSE: ABBV) falls in that category. Here is why.
Since splitting off from Abbott Laboratories in 2013, AbbVie has comfortably beaten the Dow Jones.
Source Fool.com
